Understanding health innovation adoption: A realist evaluation of pulse oximeter implementation in primary care for children under five in four West African countries

preprint OA: closed CC-BY-ND-4.0
📄 Open PDF Full text JSON View at publisher
Full text 71,919 characters · extracted from preprint-html · click to expand
Understanding health innovation adoption: A realist evaluation of pulse oximeter implementation in primary care for children under five in four West African countries | medRxiv /* */ /* */ <!-- <!-- /*! * yepnope1.5.4 * (c) WTFPL, GPLv2 */ (function(a,b,c){function d(a){return"[object Function]"==o.call(a)}function e(a){return"string"==typeof a}function f(){}function g(a){return!a||"loaded"==a||"complete"==a||"uninitialized"==a}function h(){var a=p.shift();q=1,a?a.t?m(function(){("c"==a.t?B.injectCss:B.injectJs)(a.s,0,a.a,a.x,a.e,1)},0):(a(),h()):q=0}function i(a,c,d,e,f,i,j){function k(b){if(!o&&g(l.readyState)&&(u.r=o=1,!q&&h(),l.onload=l.onreadystatechange=null,b)){"img"!=a&&m(function(){t.removeChild(l)},50);for(var d in y[c])y[c].hasOwnProperty(d)&&y[c][d].onload()}}var j=j||B.errorTimeout,l=b.createElement(a),o=0,r=0,u={t:d,s:c,e:f,a:i,x:j};1===y[c]&&(r=1,y[c]=[]),"object"==a?l.data=c:(l.src=c,l.type=a),l.width=l.height="0",l.onerror=l.onload=l.onreadystatechange=function(){k.call(this,r)},p.splice(e,0,u),"img"!=a&&(r||2===y[c]?(t.insertBefore(l,s?null:n),m(k,j)):y[c].push(l))}function j(a,b,c,d,f){return q=0,b=b||"j",e(a)?i("c"==b?v:u,a,b,this.i++,c,d,f):(p.splice(this.i++,0,a),1==p.length&&h()),this}function k(){var a=B;return a.loader={load:j,i:0},a}var l=b.documentElement,m=a.setTimeout,n=b.getElementsByTagName("script")[0],o={}.toString,p=[],q=0,r="MozAppearance"in l.style,s=r&&!!b.createRange().compareNode,t=s?l:n.parentNode,l=a.opera&&"[object Opera]"==o.call(a.opera),l=!!b.attachEvent&&!l,u=r?"object":l?"script":"img",v=l?"script":u,w=Array.isArray||function(a){return"[object Array]"==o.call(a)},x=[],y={},z={timeout:function(a,b){return b.length&&(a.timeout=b[0]),a}},A,B;B=function(a){function b(a){var a=a.split("!"),b=x.length,c=a.pop(),d=a.length,c={url:c,origUrl:c,prefixes:a},e,f,g;for(f=0;f<d;f++)g=a[f].split("="),(e=z[g.shift()])&&(c=e(c,g));for(f=0;f<b;f++)c=x[f](c);return c}function g(a,e,f,g,h){var i=b(a),j=i.autoCallback;i.url.split(".").pop().split("?").shift(),i.bypass||(e&&(e=d(e)?e:e[a]||e[g]||e[a.split("/").pop().split("?")[0]]),i.instead?i.instead(a,e,f,g,h):(y[i.url]?i.noexec=!0:y[i.url]=1,f.load(i.url,i.forceCSS||!i.forceJS&&"css"==i.url.split(".").pop().split("?").shift()?"c":c,i.noexec,i.attrs,i.timeout),(d(e)||d(j))&&f.load(function(){k(),e&&e(i.origUrl,h,g),j&&j(i.origUrl,h,g),y[i.url]=2})))}function h(a,b){function c(a,c){if(a){if(e(a))c||(j=function(){var a=[].slice.call(arguments);k.apply(this,a),l()}),g(a,j,b,0,h);else if(Object(a)===a)for(n in m=function(){var b=0,c;for(c in a)a.hasOwnProperty(c)&&b++;return b}(),a)a.hasOwnProperty(n)&&(!c&&!--m&&(d(j)?j=function(){var a=[].slice.call(arguments);k.apply(this,a),l()}:j[n]=function(a){return function(){var b=[].slice.call(arguments);a&&a.apply(this,b),l()}}(k[n])),g(a[n],j,b,n,h))}else!c&&l()}var h=!!a.test,i=a.load||a.both,j=a.callback||f,k=j,l=a.complete||f,m,n;c(h?a.yep:a.nope,!!i),i&&c(i)}var i,j,l=this.yepnope.loader;if(e(a))g(a,0,l,0);else if(w(a))for(i=0;i (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0];var j=d.createElement(s);var dl=l!='dataLayer'?'&l='+l:'';j.src='//www.googletagmanager.com/gtm.js?id='+i+dl;j.type='text/javascript';j.async=true;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-P4HH5NV'); Skip to main content Home About Submit ALERTS / RSS Search for this keyword Advanced Search Understanding health innovation adoption: A realist evaluation of pulse oximeter implementation in primary care for children under five in four West African countries Sarah Louart , Habibata Balde , Abdourahmane Coulibaly , Abdoua Elhadji Dagobi , Kadidiatou Kadio , Gildas Boris Hedible , Valériane Leroy , Emilie Robert , View ORCID Profile Valéry Ridde , AIRE study group doi: https://doi.org/10.1101/2025.01.26.25321135 Sarah Louart 1 University of Lille, CNRS, UMR 8019 - CLERSE - Centre Lillois d’Études et de Recherches Sociologiques et Économiques , F-59000 Lille, France Find this author on Google Scholar Find this author on PubMed Search for this author on this site For correspondence: sarah.louart{at}gmail.com Habibata Balde 2 African Center of Excellence for the Prevention and Control of Communicable Diseases (CEA-PCMT), Université Gamal Abdel Nasser de Conakry , Republic of Guinea Find this author on Google Scholar Find this author on PubMed Search for this author on this site Abdourahmane Coulibaly 3 Faculté de Médecine et d’Odontostomatologie , Mali 4 IRL 3189, Santé, Environnement, Sociétés (USTTB- Bamako, UCAD- Dakar, CNR - France, CNST-Ouagadougou) Find this author on Google Scholar Find this author on PubMed Search for this author on this site Abdoua Elhadji Dagobi 5 Université Abdou Moumouni de Niamey , Niger Find this author on Google Scholar Find this author on PubMed Search for this author on this site Kadidiatou Kadio 6 Institut de Recherche en Science de la Santé du Centre National de la Recherche Scientifique et Technologique (IRSS/CNRST) Ouagadougou , Burkina Faso Find this author on Google Scholar Find this author on PubMed Search for this author on this site Gildas Boris Hedible 7 Center for Epidemiology and Research in Population Health (CERPOP) , UMR 1295, Inserm, University Paul Sabatier Toulouse 3 , France Find this author on Google Scholar Find this author on PubMed Search for this author on this site Valériane Leroy 7 Center for Epidemiology and Research in Population Health (CERPOP) , UMR 1295, Inserm, University Paul Sabatier Toulouse 3 , France Find this author on Google Scholar Find this author on PubMed Search for this author on this site Emilie Robert 8 ICARE, Ecole de santé publique de l’Université de Montréal (ESPUM) , Montréal, Québec, Canada Find this author on Google Scholar Find this author on PubMed Search for this author on this site Valéry Ridde 9 Université Paris Cité , IRD, INSERM, Ceped, F-75006 Paris, France Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Valéry Ridde Abstract Full Text Info/History Metrics Supplementary material Preview PDF Abstract Introduction Hypoxemia is an important contributor to child mortality, particularly in low-resource settings where diagnostic tools are scarce. The AIRE project introduced pulse oximeters (POs) into 202 primary healthcare centres (PHCs) in Burkina Faso, Guinea, Mali, and Niger, integrating them into the Integrated Management of Childhood Illness (IMCI) guidelines. This initiative aimed to strengthen diagnostic capacities for identifying hypoxemia and to improve care management for critically ill children under five. This study examined how healthcare workers (HCWs) adopted POs and explored the contexts and mechanisms influencing their adoption. Methods We conducted a realist evaluation to analyse adoption patterns, focusing on interactions between the Intervention, Contexts, Actors, Mechanisms, and Outcomes (ICAMO configurations). Data collection included 299 interviews with HCWs, patients’ families, and institutional actors, conducted in 16 selected PHCs, at the institutional level, and in district hospitals, complemented by site observations. Analysis was performed using NVivo software, identifying ICAMO configurations as demi- regularities to explain variations in PO use and adoption. Results Training enabled HCWs to recognize the utility of POs, further motivating their use. Support-focused supervision fostering a sense of support, while control-focused approaches sometimes resulted in mechanical use driven by external pressure. In contexts of high workloads and children’s agitation, difficulties in using POs were observed. In settings with limited diagnostic tools, POs increased HCWs’ diagnostic confidence, encouraging adoption and improving decision-making. Observing or knowing the benefits of POs on children’s health provided HCWs with a sense of relief and pride, further reinforcing PO adoption. However, structural barriers and challenges related to institutional adoption may threaten long-term use. Conclusion This study highlights the necessary conditions for adopting POs in PHCs. While widely used by healthcare workers, addressing challenges related to training, supply chain logistics, and referral systems to hospitals is essential to ensure long-term sustainability and improve child health outcomes. What is already known on this topic Severe hypoxemia significantly contributes to child mortality, especially in low- resource settings lacking adequate diagnostic tools. Pulse oximeters (POs) are effective in detecting hypoxemia and guiding referrals, particularly when integrated into the Integrated Management of Childhood Illness (IMCI) guidelines. What this study adds Using a realist evaluation approach, this study identified diverse responses to PO implementation, explaining the reasons for non-use, mechanical use, use, and adoption. POs appear to be predominantly adopted at an individual level. Findings highlight the critical role of boosting confidence in health care providers’ diagnostics, as well as the sense of relief and pride derived from participating in the care of children, to support adoption. Structural and institutional challenges, including training, supply chain issues, device maintenance, and referral system inadequacies, were found to potentially hinder the sustainability of PO adoption. How this study might affect research, practice, or policy The study provides valuable insights into the contexts and mechanisms that facilitate or hinder the adoption of POs, which may also inform the integration of other diagnostic tools into primary healthcare systems. Policymakers and healthcare implementers can utilize these findings to design tailored strategies to implement similar interventions in other contexts. Introduction Infectious diseases, particularly respiratory infections are leading causes of child mortality [ 1 , 2 ], especially in sub-Saharan Africa, where socio-economic factors such as poverty and inadequate home ventilation contribute to their high prevalence [ 3 ]. West Africa has the highest child mortality rates under five, largely due to infectious diseases. However, efforts and resources to address this public health issue remain insufficient [ 4 ]. Severe hypoxemia, defined as a blood oxygen concentration below 90%, is a key indicator of the severity of acute lower respiratory tract infections [ 5 ] but also a marker of severity for other common conditions like malaria and malnutrition [ 6 ]. In low- and middle-income countries, hospital studies report significant prevalence rates of hypoxemia, varying according to age, disease type, and illness severity [ 7 – 9 ]. This severe hypoxemia substantially increases the risk of death in children [ 5 ]. However, clinical symptoms alone are insufficient to reliably detect hypoxemia, underscoring the interest of devices that measure oxygen saturation for identifying children requiring urgent care [ 10 , 11 ], including oxygen therapy [ 12 , 13 ]. International calls have long advocated for improved access to oxygen and diagnostic tools like pulse oximeters (PO) [ 13 ], which measure oxygen saturation and help detect hypoxemia cases. To enhance child healthcare, the World Health Organization (WHO) introduced the Integrated Management of Childhood Illness (IMCI) strategy in the 1990s, aiming to prevent and treat severe childhood illnesses in low-resource settings [ 14 ]. In 2014, the IMCI clinical guidelines were updated to include specific recommendations for respiratory diseases, advocating for the use of PO “when available” and the transfer to facilities equipped to administer oxygen when oxygen saturation falls below 90% [ 15 ]. However, access to PO and oxygen in low-income countries remains inadequate [ 16 ], especially in primary care settings [ 17 ], limiting the potential impact of this recommendation. Although studies have demonstrated the effectiveness of PO for identifying critical cases that could go unnoticed with IMCI alone [ 18 , 19 ], evidence on its impact at the decentralized level remains scarce. A study in Uganda is one of the few to examine this aspect [ 20 ]. Furthermore, there is a significant gap in qualitative research exploring the processes of PO implementation and adoption, particularly in decentralized primary care settings [ 21 ]. Recently, a realist evaluation in Nigeria provided valuable insights, revealing that PO adoption in these settings was both limited and uneven [ 22 ]. To tackle these challenges, the AIRE project was implemented in four West African countries: Burkina Faso, Guinea, Mali, and Niger. Led by a consortium of NGOs, this project aimed to strengthen diagnostic capacities for severe hypoxemic cases at the primary care level by introducing the routine use of PO during IMCI consultations. A multi-faceted study was conducted to understand the introduction of PO in these settings [ 23 ]. A key element in disseminating innovations is understanding the factors influencing their adoption (or non-adoption) [ 24 ]. Given the complexity of implementing innovations in primary health care centres (PHCs), a realist approach [ 25 ] was used to explore the contexts and mechanisms that facilitate or hinder the adoption of PO by healthcare workers (HCWs). This study sought to answer the overarching question: how does the AIRE project work (or not), for whom, in which specific contexts, and why? It further explored how HCWs responded to the intervention, which contextual elements shaped these responses, and what effects these responses produced on the use and adoption of PO. Methods Intervention and research sites The AIRE intervention was implemented from July 2019 to December 2022 in two health districts within each of the four countries: Burkina Faso, Guinea, Mali, and Niger ( Figure 1 ), encompassing 202 PHCs and 8 district hospitals. The IMCI guidelines were primarily utilized in paper format, except in Burkina Faso and one district in Mali, where electronic IMCI was employed as part of the Integrated e- Diagnostic Approach (IeDA) program [ 26 ]. Project activities included training in PO use and refreshing HCWs in IMCI, distributing POs, conducting supervision visits, and strengthening care capacities at PHCs (basic medicines and medical equipment) and district hospitals (POs and oxygen concentrators). Download figure Open in new tab Figure 1 Countries and health districts involved in the AIRE study The research was conducted primarily in 16 selected PHCs (four per country), designated as sites 1 through 4 in each country. Additional investigations occurred at hospital and institutional levels, including district teams and ministries. Details on the intervention, research site selection criteria, and eligibility criteria for children’s PO use are outlined in the study protocol [ 23 ]. Characteristics of the sites are described elsewhere [ 27 ]. Study design To gain an in-depth understanding of HCWs’ adoption or non-adoption of PO, we conducted a realist evaluation [ 25 ]. This approach seeks to understand how and why an intervention produces specific effects by exploring underlying mechanisms— namely, the reasoning and reactions of individuals in response to resources provided through the intervention [ 28 ]. These mechanisms are triggered only in specific contexts, requiring an analysis of the dynamic interactions between context, mechanisms, and observed outcomes. To model this dynamic, realist evaluation employs Context-Mechanism-Outcome (CMO) configurations as a heuristic tool, facilitating the development of analytical and robust explanations of results. We began by formulating our hypotheses using Intervention-Context-Actor-Mechanism- Outcome (ICAMO) configurations to specify the intervention and target actors of our study (PHC HCWs) [ 29 ]. As we moved toward a higher level of abstraction, we employed CMO configurations to develop the middle-range theory (MRT). The realist evaluation process begins with reconstructing the program theory, defined as the underlying assumptions about how an intervention is intended to work and the impacts it is expected to have [ 30 ]. These initial assumptions are gradually refined, aiming to develop a middle-range theory (MRT) [ 31 ]. Realist evaluation thus favours theoretical generalization [ 32 ], supporting the formulation of practical and contextualized recommendations for policymakers by progressively refining the program’s initial theory. Our realist evaluation design is illustrated in Figure 2 . We organized three research workshops to guide the evaluation: the first framed the research and refined the initial intervention model through discussions with coordination teams at both country and international levels, while the second and third focused on adjusting and refining hypotheses, leading to the formulation of 26 theoretical hypotheses. These hypotheses were developed based on preliminary field data, scientific literature— including realist studies on PO use in Nigerian hospitals [ 33 ], a realist review on access to oxygen, and extensive literature on innovation adoption [ 34 – 36 ]. The process of refining the program theory is detailed in Appendix 1. Download figure Open in new tab Figure 2 Realist evaluation design of the AIRE Project This article follows the RAMESES guidelines for reporting realist evaluations to ensure transparency and rigor [ 37 ]. Data collection We conducted two rounds of data collection ( Figure 3 ). The first (T1) occurred in November and December 2021, approximately six months after introducing PO in the PHCs. The second (T2) took place in October and November 2022, at the end of the project’s main activities. Experienced national qualitative researchers conducted in- depth individual interviews after obtaining written consent. Interviews were conducted in French or local languages, depending on the location and participants. Download figure Open in new tab Figure 3 Timeline of the study In both phases, we employed exhaustive sampling for HCWs consulting children under five at PHCs and available during the survey. For other groups, including families of the children, HCWs at district hospitals, and individuals involved in project monitoring at the institutional level, we used purposive sampling [ 23 ]. Additionally, observations were conducted in PHCs, including consultation observations. Data Analysis The interviews conducted with HCWs in PHCs serve as the primary data source for this study. Additional interviews with other participants and observations carried out in PHCs, were used for data triangulation, further strengthening the realist analysis. Our analysis focused on identifying four main effects of the intervention: use, non- use, unsustainable use (mechanical, circumstantial, or temporary), and adoption of the PO. Use encompasses any application of the PO, whether systematic, anecdotal, mechanical, or performed under constraint. It includes both instances that may progress toward adoption and those that remain unsustainable. Importantly, use is considered a necessary step toward adoption, as specific configurations associated with use can generate feedback loops that ultimately support adoption. Adoption implies a voluntary and sustained integration of the PO into HCWs’ practices. Data analysis followed an iterative process guided by realist methodology. Hypotheses were examined across all interviews and progressively refined based on emerging findings. To ensure rigor and reliability, double coding was conducted using Nvivo12. An approach by case studies was adopted, with cases selected for their distinct characteristics to guide data collection. Comparisons were then conducted within and across cases to identify patterns, refine interpretations, and strengthen the analysis [ 32 ]. The list of hypotheses was further revised and refined by integrating empirical findings with existing literature. This iterative process ultimately led to the formulation of a MRT. Ethical Approvals As detailed in the study protocol, this research received approval from the ethics committees of the four participating countries, as well as from the ethics committees of WHO and Inserm [ 22 ]. Patient and public involvement Data collection was authorized by ethics committees and ministries of health. The study participants were not directly involved in the analysis, interpretation of results, or manuscript preparation. Results During the two rounds of data collection, 299 interviews were conducted with various target populations. Table 1 presents the distribution by timeframe and country. Table 2 presents the different configurations of our MRT, developed based on the demi- regularities identified in the data, supported by examples of citations. View this table: View inline View popup Download powerpoint Table 1. Distribution of Interviews by data collection period, respondent groups, and country (N=299). View this table: View inline View popup Table 2. Configurations of the Middle-Range Theory We present the main configurations identified in the data, outlining the key contexts, mechanisms, and outcomes that explain the use and adoption of pulse oximeters in primary healthcare settings. These results are summarized in Figure 4 . Download figure Open in new tab Figure 4 Middle-range theory of PO adoption PO use The introduction of the PO at the decentralized level triggered a range of responses and mechanisms among PHC HCWs. First, in these settings, diagnostic technologies are typically reserved for higher levels of care and high-status professionals, such as doctors. Introducing the PO at the primary care level was thus perceived as a source of pride, enhancing HCWs’ sense of legitimacy in providing care. This perception was reinforced, particularly in Burkina Faso and Mali, by the sense of privilege associated with having the PO in selected centres, especially since other PHCs in the country did not receive the device. Additionally, being part of a pilot project added pressure and motivation for HCWs to use the PO, as its potential scaling partly depended on the data collected in these research PHCs. Participation in the project fostered both a sense of pride and a responsibility to meet expectations and deliver positive outcomes. Some HCWs emphasized the need “to set an example” (Burkina Faso, T2, PHC2) or “not to disappoint” (Niger, T1, PHC3) project members. This feeling of pride was also reinforced by HCWs’ perception of increased family trust and higher attendance at PHCs. In areas where PHCs often lack diagnostic tools, the PO enhanced the centre’s image, attracting more patients and strengthening trust as families appreciated the introduction of this new technology. This perception was further confirmed by interviews with families, who expressed greater confidence in the care provided. As HCWs noted, “the quality of the consultation is there, and it attracts patients” (Guinea, T1, PHC3) and “the PO is a tool that has created more trust between us and the patients” (Mali, T1, PHC1). Another configuration underscores the key role of training in promoting PO use by raising awareness of its practical benefits. This effect became particularly evident during the second round of data collection, as the progressive training sessions conducted through the AIRE project enabled an increasing number of HCWs to recognize the value of the PO in their practice. Training sessions not only enhanced HCWs’ understanding of the PO’s value in refining diagnoses and detecting emergency situations related to hypoxemia, but also emphasized its role in facilitating referrals to hospitals where children could access oxygen therapy. External motivation also influenced PO use, with two configurations emerging: control-focused supervision and support-focused supervision. Monitoring took various forms, including supervision by project and district teams, the presence of clinical investigators in PHCs, and oversight by PHC managers. Support-focused supervision prioritized encouragement and guidance, fostering a more voluntary use of the PO. This approach helped HCWs feel supported and reinforced their understanding of the project’s importance. This support came from various sources. In some cases, the presence of clinical investigators was positively received. When supervision by the project was inclusive – involving all staff members rather than focusing solely on PHC managers – it also further promoted PO use. Positive support from PHC managers was also highlighted by several HCWs. Managers who actively used the PO themselves were perceived as setting an example and “showing its importance to others” (Burkina Faso, T1, PHC3). This visible leadership encouraged other HCWs to view the PO as an essential tool, reinforcing their commitment to use it. Po mechanical use In contrast, control-focused supervision emphasized performance monitoring and compliance. Clinical investigators, employed by the project and present daily in the PHCs for over a year, exerted a notable influence on PO use, particularly highlighted in Burkina Faso and Guinea. Investigators, tasked with collecting clinical data, actively pressured HCWs to use the PO by checking registers, insisting on its use, and reminding those who did not comply. As one HCW noted: “they put a lot of pressure on us” (Guinea, T1, PHC2). In some cases, PHC managers also contributed to integrating PO into daily practices by exerting pressure to ensure its use. While this was not observed in Guinea, it was reported in nearly all other cases. In Niger, one HCW explained: “I assure you that she [PHC manager] monitors strictly! So, no one wants to be the source of any issues!” (Niger, T2, PHC3). This pressure often took the form of record checks, consultation monitoring, or reminders of responsibility. Supervision was also sometimes perceived as a form of control, particularly during the second phase of data collection and in Burkina Faso. However, the perception of supervision varied depending on how it was implemented. In some cases, supervisors focused more on outcomes than support, leading HCWs to prepare to avoid exposing errors. Additionally, the digitization of IMCI protocols sometimes compelled PO use. The electronic consultation register required oxygen saturation measurements to proceed with diagnoses, reinforcing PO use in PHCs implementing electronic IMCI. Challenges in using the PO We also identified contexts that may hinder PO use. Children’s agitation emerged as the primary reason for non-use, particularly during the first phase of data collection. This agitation not only prolonged the time required to use the device but, in some cases, made its use entirely impossible. Observations conducted in PHCs confirmed these challenges, as HCWs were sometimes seen struggling to obtain readings on agitated children. Often linked to a general fear of healthcare facilities or the use of the malaria Rapid Diagnostic Test (mRDT) requiring a puncture, this issue prompted HCWs to adapt their practices. For example, some HCWs used the PO at the beginning of the consultation (before the mRDT) and employed various strategies to calm children and demonstrate that the device is painless. Another barrier to PO use was the increased workload, particularly reported in Burkina Faso. This burden was especially evident in high-volume settings with limited staff, making PO use challenging due to time constraints, particularly during peak periods or when dealing with impatient patients. To alleviate this burden, some PHCs implemented strategies such as separating adult and child consultations, using the PO during triage, or conducting paediatric consultations with two HCWs. However, the feasibility of these solutions remained dependent on sufficient human resources. PO adoption Two configurations were identified as pathways to adoption. The first configuration centred on enhanced diagnostic confidence among HCWs. Prior to the introduction of the PO, many described challenges in making accurate diagnoses: “Before, we consulted children with uncertainty” (Mali, T1, PHC1). In the absence of adequate equipment, diagnoses often relied on individual judgment, leading to difficult decisions – for example, whether to keep a sick child for observation or send them home despite signs of worsening health. Introducing the PO reduced this uncertainty, providing HCWs with a greater sense of confidence and calm in their decision- making: “The PO allows me to be sure of what I’m doing and saves lives” (Mali, T2, PHC4). The second configuration was linked to HCWs’ direct observation of the PO’s usefulness in improving childcare, which gave them a sense of relief and motivation to adopt the device in their daily practice. This response was particularly noted in Mali. Although the benefits of the PO were often inferred due to the limited availability of oxygen at the decentralized level, HCWs reported feeling reassured when they received updates about a child’s improved condition, either through caregivers’ feedback or follow-up exchanges with hospital staff. Structural and institutional barriers to PO adoption While many positive configurations supporting the use and adoption of the PO were identified, our interviews, particularly with institutional-level respondents, highlighted several structural and institutional factors that could undermine these dynamics and hinder long-term adoption. Adoption often depends on HCWs’ ability to observe the benefits of the PO in practice. However, structural limitations related to follow-up care and oxygen delivery services can restrict this experience: “If you don’t have the ability to provide ventilation for the child on-site… the problem is not solved.” (Guinea, institutional actor). Since oxygen therapy is typically only available in hospital settings, HCWs must rely on patient transfers, which can be complex and poorly coordinated, especially following the end of the AIRE project. One HCW explained: “it’s not the same as when the investigators were around.” (Niger, T2, PHC1). In the interviews, the end of project supervision—previously valued for its monitoring and reminders— was often perceived as a threat to the sustained use of the PO, as ongoing support mechanisms will no longer be available. Potential barriers also include the relatively low prevalence of hypoxemia within the total volume of consultations observed in decentralized settings compared to hospital environments. Some HCWs reported rarely encountering hypoxemia cases, which may reduce confidence in the diagnostic value of the PO over time. Additionally, while this study focused on individual adoption, interviews revealed that sustainability also depends on institutional integration, which remains limited due to resource constraints. Despite signs of individual adoption, PHCs often showed passivity toward institutionalizing the PO, relying instead on NGOs to sustain its integration through continued project support or new initiatives. Institutional challenges were further exacerbated by staff turnover and insufficient training for newly recruited HCWs, raising concerns about the continuity of PO use. As one institutional actor warned, “In three years, none [of the staff] will be trained to use the PO” (Burkina Faso, institutional actor). Similarly, the absence of maintenance and replacement systems for broken devices poses another barrier to sustainability, as illustrated by a respondent in Niger who stated, “the care of the child with the pulse oximeter will stop… and we have no way to bring in a new device” (Niger, institutional actor). Discussion This study highlights that individual adoption of the PO in PHCs was relatively high, a trend further supported by quantitative data from the AIRE project, which confirmed high utilization rates [ 38 ]. However, the intervention produced four distinct outcomes regarding the use and adoption of the PO. Non-utilization was primarily observed in high-workload settings and in cases where the device could not be used on agitated children. Mechanical use occurred when external pressures, such as supervision, motivated HCWs to use the device out of obligation or constraint, raising concerns about sustainability. Utilization was linked with increased awareness of the PO’s usefulness, supportive environments, and feelings of pride and privilege in accessing the device. Finally, adoption reflected strengthened diagnostic confidence and a sense of pride and relief from contributing to improved care for children. Several contextual elements shaped responses to the intervention and influenced PO use. Being trained emerged as central, not only for mastering the tool but, more importantly, for recognizing its practical utility. Without multiple waves of training and formative supervision, the use of PO could have been negatively affected. As shown in other studies, limited training risks undermining collective ownership and shared responsibility [ 39 ]. Quantitative data from another AIRE study confirmed that training is strongly associated with PO acceptability [ 38 ]. The decentralized implementation of the intervention also influenced HCWs’ perceptions. In settings with limited diagnostic tools, the PO was often regarded as a valuable innovation, enhancing confidence in diagnosis and decision-making. This aligns with findings from a realist study, which highlighted that the scarcity of diagnostic tools can encourage the adoption of new technologies [ 39 ]. Indeed, perceptions of its value varied across settings. In Nigeria, some HCWs questioned whether the PO provided added diagnostic value or simply delayed referrals they already deemed necessary [ 22 ]. In contrast, studies conducted in settings with limited access to laboratory services and located farther from hospitals emphasized the PO’s role in assessment, stabilization, and referrals [ 40 , 41 ]. Supervision and external motivation also influenced responses, though the impact varied depending on how supervision was perceived. A realist evaluation in Guatemala distinguished between control-focused supervision, which emphasized pressure to meet targets, and support-focused supervision, which prioritized encouragement and practical guidance [ 42 ]. Studies have shown that leadership styles and supervisory approaches can significantly influence adoption rates. For example, in Kenya, differences in PO use were partially attributed to variations in leadership styles among senior doctors [ 43 ]. In Nigeria, the absence of external support negatively affected PO adoption rates [ 22 ]. The end of AIRE project supervision was often seen as a risk to sustained use, given the lack of established structures for ongoing support. Practical and structural constraints also shaped responses to the intervention. Children’s agitation during measurements was widely reported as a barrier, consistent with findings from other studies [ 40 , 44 ]. High workloads and limited human resources complicated consistent use, reflecting challenges noted in studies on other diagnostic technologies [ 45 , 46 ]. In Guinea, where the number of consultations was lower during the AIRE project, these challenges were less reported [ 47 ]. The intervention elicited a range of responses among HCWs, influenced by perceptions of the PO as a valuable innovation and by different types of motivation. We have seen that the PO was widely regarded as an important tool in decentralized settings, where diagnostic technologies are often scarce. This perception motivated HCWs, who viewed access to advanced equipment as a privilege and a source of legitimacy. Previous studies have highlighted how the social positioning and roles of HCWs influence their relationship with technology [ 48 , 49 ]. Abejirinde et al. [ 39 ] also found that a sense of pride in being selected for a project can facilitate the adoption of innovations. This dynamic was further reinforced by increased patient trust [ 38 ], echoing findings from other studies where families’ confidence in HCWs improved after the introduction of the PO [ 40 , 43 , 50 ]. HCWs’ motivations also varied depending on whether they were externally driven or internally rooted. Insights from Self-Determination Theory [ 51 ] suggest that autonomous motivation, grounded in personal values, is generally more sustainable than controlled motivation, which depends on external pressures. In this context, HCWs’ ownership of the PO was strengthened when key actors – such as supervisors or managers – were perceived as supportive rather than controlling. Supportive interactions encouraged HCWs to see the PO as a tool to improve care, while supervision perceived as imposing constraints sometimes resulted in mechanical use without genuine engagement. Interestingly, mechanical use, initially driven by external reminders, did not necessarily hinder adoption. Over time, reliance on external motivation sometimes transitioned into voluntary adoption, reinforced by repeated positive experiences with the PO. Similar patterns were observed in Nigeria, where constrained use eventually evolved into internalized adoption as HCWs gained familiarity and confidence in the tool [ 33 ]. The PO also enhanced HCWs’ diagnostic confidence, which proved to be a key mechanism promoting adoption. HCWs reported greater certainty in their assessments, leading to faster decision-making. Comparable findings were observed in India [ 52 ], Malawi, and Bangladesh [ 40 ]. However, this effect was less pronounced in hospital settings, where HCWs already had access to more diagnostic equipment and training. Within the AIRE project, referral rates for hypoxemic cases were higher than for other severe cases without hypoxemia [ 53 ], suggesting a greater reliance on PO-based diagnostics. Similar trends were noted in Malawi [ 41 ] and India [ 52 ]. Beyond diagnostic confidence, HCWs described feelings of pride and relief when observing the PO’s positive effects on patient care, further motivating its adoption. Seeing tangible benefits reinforced their belief in the device’s utility, aligning with the concepts of observability [ 34 ] and result demonstrability [ 54 ]. These concepts emphasize that the ability to observe and measure a tool’s impact encourages its adoption. A realist review similarly identified the ability to observe positive outcomes as a key motivator for HCWs to use oxygen [ 55 ]. Finally, our findings also highlight the importance of addressing structural and institutional challenges to ensure the long-term adoption and sustainability of the PO. While improved diagnostics enhanced decision-making, limited access to treatment and the need for emergency hospital referrals for oxygen therapy could demotivate HCWs, diminishing the perceived effectiveness of the PO. Well-documented barriers to hospital referrals—including distance, poor road conditions, lack of transportation, and family costs—further restricted access to care [ 56 , 57 ]. The highest number of referrals during the project was reported in Niger, likely due to the close proximity of PHCs to hospitals, particularly in the capital [ 58 ]. Additional challenges included supply chain issues, device maintenance, and training gaps for newly recruited staff. Concerns about the absence of maintenance systems and replacement devices raised fears of disruptions in patient care, echoing findings from other studies that identified malfunctioning devices and insufficient training as major obstacles to technology adoption [ 40 , 43 , 59 ]. Despite encouraging signs of individual adoption, ensuring the sustainability of the PO requires institutional commitment to overcome these barriers. This includes formalizing its use in clinical protocols, establishing regular training programs to address staff turnover, developing reliable supply chains for maintenance and replacement and support hospital referrals and oxygen therapy delivery. Such measures are critical to prevent these challenges from undermining adoption efforts and to support the integration of the PO into health systems effectively. This study has some limitations that should be acknowledged. First, contextual and methodological biases may have influenced the findings. Social desirability bias [ 60 ] could have led HCWs to present an idealized image of their work, particularly given their dependency relationships with NGOs and donors [ 61 ]. Similar pressures to demonstrate success and secure funding are well-documented in the global health sector [ 62 ]. Additionally, practical and time constraints posed challenges to conducting realist interviews [ 63 ], partly due to limited training time for investigators and perceived power dynamics between interviewers and participants. Such challenges have been highlighted in other studies [ 64 ]. To mitigate these limitations, several strategies were implemented. Investigators explicitly clarified their independence from the NGOs involved, encouraging participants to speak freely and anonymously. Furthermore, triangulation of data sources was used to cross-verify information and enhance the reliability of the results. Despite these limitations, this study provides one of the first applications of realist evaluation to explore the individual adoption of a technological innovation in primary health care settings. It offers a solid foundation for future research on the dynamics of technology adoption in similar contexts. Conclusion This study suggests that POs are generally used and even adopted by HCWs in decentralized contexts, especially where diagnostic tools are scarce, and their benefits for patient care are observable. Its use enhances diagnostic confidence and reinforces perceptions of its utility. However, structural and institutional challenges, including supply, maintenance, staff training, and access to hospital for oxygen treatment, may threaten its long-term integration into health systems. Addressing these barriers will be essential to ensure the sustainability of the PO and its impact on child health outcomes. The AIRE Research Study Group: Country investigators Ouagadougou, Burkina Faso: S. Yugbaré Ouédraogo (PI), V. M. Sanon Zombré (CoPI), Conakry, Guinea: M. Sama Cherif (CoPI), I. S. Diallo (CoPI), D. F. Kaba, (PI). Bamako, Mali: A. A. Diakité (PI), A. Sidibé, (CoPI). Niamey, Niger: H. Abarry Souleymane (CoPI), F. Tidjani Issagana Dikouma (PI). Research coordinators & data centers: Inserm U1295, Toulouse 3 University, France: H. Agbeci (Int Health Economist), L. Catala (Research associate), D. L. Dahourou (Research associate), S. Desmonde (Research associate), E. Gres (PhD Student), G. B. Hedible (Int research project manager), V. Leroy (research coordinator), L. Peters Bokol (Int clinical research monitor), J. Tavarez (Research project assistant), Z. Zair (Statistician, Data scientist). CEPED, IRD, Paris, France: S. Louart (process manager), V. Ridde (process coordination). Inserm U1137, Paris, France: A. Cousien (Research associate). Inserm U1219 , EMR271 IRD, Bordeaux University, France : R. Becquet (Research associate), V. Briand (Research associate), V. Journot (Research associate). PACCI, CHU Treichville, Abidjan, Côte d’Ivoire : S. Lenaud (Int data manager), C. N’Chot (Research associate), B. Seri (Supervisor IT), C. Yao (data manager supervisor). Consortium NGOs partners: Alima-HQ (consortium lead), Dakar, Sénégal : G. Anago (Int Monitoring Evaluation Accountability And Learning Officer), D. Badiane (Supply chain manager), M. Kinda (Director), D. Neboua (Medical officer), P. S. Dia (Supply chain manager), S. Shepherd (referent NGO), N. di Mauro (Operations support officer), G. Noël (Knowledge broker), K. Nyoka (Communication and advocacy officer), W. Taokreo (Finance manager), O. B. Coulidiati Lompo (Finance manager), M. Vignon (Project Manager). Alima, Conakry, Guinea: P. Aba (clinical supervisor), N. Diallo (clinical supervisor), M. Ngaradoum (Medical Team Leader), S. Léno (data collector), A. T. Sow (data collector), A. Baldé (data collector), A. Soumah (data collector), B. Baldé (data collector), F. Bah (data collector), K. C. Millimouno (data collector), M. Haba (data collector), M. Bah (data collector), M. Soumah (data collector), M. Guilavogui (data collector), M. N. Sylla (data collector), S. Diallo (data collector), S. F. Dounfangadouno (data collector), T. I. Bah (data collector), S. Sani (data collector), C. Gnongoue (Monitoring Evaluation Accountability And Learning Officer), S. Gaye (Monitoring Evaluation Accountability And Learning Officer), J. P. Y. Guilavogui (Clinical Research Assistant), A. O. Touré (Country health economist), J. S. Kolié (Country clinical research monitor), A. S. Savadogo (country project manager). Alima, Bamako, Mali: F. Sangala (Medical Team Leader), M. Traore (Clinical supervisor), T. Konare (Clinical supervisor), A. Coulibaly (Country health economist), A. Keita (data collector), D. Diarra (data collector), H. Traoré (data collector), I. Sangaré (data collector), I. Koné (data collector), M. Traoré (data collector), S. Diarra (data collector), V. Opoue (Monitoring Evaluation Accountability And Learning Officer), F. K. Keita (medical coordinator), M. Dougabka (Clinical research assistant then Monitoring Evaluation Accountability And Learning Officer), B. Dembélé (data collector then Clinical research assistant), M. S. Doumbia (country health economist), G. D. Kargougou (country clinical research monitor), S. Keita (country project manager). Solthis-HQ, Paris : S. Bouille (NGO referent), S. Calmettes (NGO referent), F. Lamontagne (NGO referent). Solthis, Niamey: K. H. Harouna (clinical supervisor), B. Moutari (clinical supervisor), I. Issaka (clinical supervisor), S. O. Assoumane (clinical supervisor), S. Dioiri (Medical Team Leader), M. Sidi (data collector), K. Sani Alio (Country supply chain officer), S. Amina (data collector), R. Agbokou (Clinical research assistant), M. G. Hamidou (Clinical Research Assistant), S. M. Sani (Country health economist), A. Mahamane, Aboubacar Abdou (data collector), B. Ousmane (data collector), I Kabirou (data collector), I. Mahaman (data collector), I Mamoudou (data collector), M. Baguido (data collector), R. Abdoul (data collector), A. Sahabi (data collector), F. Seini (data collector), Z. Hamani (data collector), L-Y B Meda (Country clinical research monitor), Mactar Niome (country project manager), X. Toviho (Monitoring Evaluation Accountability And Learning Officer), I. Sanouna (Monitoring Evaluation Accountability And Learning Officer), P. Kouam (program officer). Terre des hommes-HQ, Lausanne: S. Busière (NGO referent), F. Triclin (NGO referent). Terre des hommes, BF: A. Hema (country project manager), M. Bayala (IeDA IT), L. Tapsoba (Monitoring Evaluation Accountability And Learning Officer), J. B. Yaro (Clinical research assistant), S. Sougue (Clinical research assistant), R. Bakyono (Country health economist), A. G. Sawadogo (Country clinical research monitor), A. Soumah (data collector), Y. A. Lompo (data collector), B. Malgoubri (data collector), F. Douamba (data collector), G. Sore (data collector), L. Wangraoua (data collector), S. Yamponi (data collector), S. I. Bayala (data collector), S. Tiegna (data collector), S. Kam (data collector), S. Yoda (data collector), M. Karantao (data collector), D. F. Barry (Clinical supervisor), O. Sanou (clinical supervisor), N. Nacoulma (Medical Team Leader), N. Semde (clinical supervisor), I. Ouattara (Clinical supervisor), F. Wango (clinical supervisor), Z. Gneissien (clinical supervisor), H. Congo (clinical supervisor). Terre des hommes, Mali: Y. Diarra (clinical supervisor), B. Ouattara (clinical supervisor), A. Maiga (data collector), F. Diabate (data collector), O. Goita (data collector), S. Gana (data collector), S. Diallo (data collector), S. Sylla (data collector), D. Coulibaly (Tdh project manager), N. Sakho (NGO referent). Country SHS team: Burkina Faso : K. Kadio (consultant and research associate), J. Yougbaré (data collector), D. Zongo (data collector), S. Tougouma (data collector), A. Dicko (data collector), Z. Nanema (data collector), I. Balima (data collector), A. Ouedraogo (data collector), A. Ouattara (data collector), S. E. Coulibaly (data collector). Guinea : H. Baldé (consultant and research associate), L. Barry (data collector), E. Duparc Haba (data collector). Mali : A. Coulibaly (consultant and research associate), T. Sidibe (data collector), Y. Sangare (data collector), B. Traore (data collector), Y. Diarra (data collector). Niger : A. E. Dagobi (consultant and research associate), S. Salifou (data collector), B. Gana Moustapha Chétima (data collector), I. H. Abdou (data collector) FOOTNOTES Contributors All authors contributed to the conceptualization of the research. HB, AC, AED, and KK conducted data collection with support from SL and the AIRE research study group. SL, HB, AC, AED, and KK carried out the data analysis. SL prepared the initial draft of this article. All authors participated in data interpretation and reviewed the final manuscript. Funding The AIRE project is funded by UNITAID, with in-kind support from Inserm and IRD. UNITAID was not involved in the design of the study, the collection, analysis and interpretation of the data, nor in the writing of the manuscript. Competing interest All authors have declared no conflict of interest. Ethics approval and consent to participate Ethics approval and consent to participate The AIRE research protocol, the information notice (translated in vernacular languages), the written consent form and any other relevant document have been submitted to each national ethics committee, to the Inserm Institutional Evaluation Ethics Committee (IEEC) and to the WHO Ethics Review Committee (WHOIZIERC). All the aforementioned ethical committees reviewed and approved the protocol and other key documents (Comité d’Ethique pour la Recherche en Santé (CERS), Burkina Faso n°2020–4IZI070; Comité National d’Ethique pour la Recherche en Santé (CNERS), Guinea n°169/CNERS/21; Comité National d’Éthique pour la Santé et les Sciences de la vie (CNESS), Mali n°127/MSDSIZICNESS; Comité National d’Ethique pour la Recherche en Santé (CNERS) Niger n°67/2020/CNERS; Inserm IEEC n°20–720; WHOIZIERC n° ERC.0003364). This study has been retrospectively registered by the Pan African Clinical Trials Registry on June 15 th , 2022, under the following Trial registration number: PACTR202206525204526. Data Availability Statement The datasets generated and analysed during the current study are not publicly available. Access to processed deidentified participant data will be made available to any third Party after the publication of the main AIRE results stated in the Pan African Clinical Trial Registry Study statement (PACTR202206525204526, registered on 06/15/2022), upon a motivated request (concept sheet), and after the written consent of the AIRE research coordinator (Valériane Leroy, valeriane.leroy{at}inserm.fr , Inserm U1295 Toulouse, France, orcid.org/0000-0003-3542-8616) obtained after the approval of the AIRE publication committee, if still active. ACKNOWLEDGMENTS We thank all the participants of this study, as well as the healthcare staff involved in the AIRE project. We also express our gratitude to the field project staff and the AIRE Research Study Group. Finally, we thank the Ministries of Health of the participating countries for their support. References 1. ↵ Vos T , Lim SS , Abbafati C , et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 . The Lancet . 2020 ; 396 :1204–22. doi: 10.1016/S0140-6736(20)30925-9 OpenUrl CrossRef PubMed 2. ↵ UN Inter-agency Group for Child Mortality Estimation . Levels & Trends in Child Mortality . 2020 . 3. ↵ Sarfo JO , Amoadu M , Gyan TB , et al. Acute lower respiratory infections among children under five in Sub-Saharan Africa: a scoping review of prevalence and risk factors . BMC Pediatr . 2023 ; 23 : 225 . doi: 10.1186/s12887-023-04033-x OpenUrl CrossRef 4. ↵ The Lancet Global . The disgraceful neglect of childhood pneumonia . The Lancet Global Health . 2018 ; 6 : e1253 . doi: 10.1016/S2214-109X(18)30495-9 OpenUrl CrossRef 5. ↵ Lazzerini M , Sonego M , Pellegrin MC . Hypoxaemia as a Mortality Risk Factor in Acute Lower Respiratory Infections in Children in Low and Middle-Income Countries: Systematic Review and Meta-Analysis . PLOS ONE . 2015 ; 10 : e0136166 . doi: 10.1371/journal.pone.0136166 OpenUrl CrossRef PubMed 6. ↵ Graham H , Bakare AA , Ayede AI , et al. Hypoxaemia in hospitalised children and neonates: A prospective cohort study in Nigerian secondary-level hospitals . EClinicalMedicine . 2019 ; 16 : 51 – 63 . doi: 10.1016/j.eclinm.2019.10.009 OpenUrl CrossRef PubMed 7. ↵ Lozano JM . Epidemiology of hypoxaemia in children with acute lower respiratory infection . Int J Tuberc Lung Dis . 2001 ; 5 : 496 – 504 . OpenUrl PubMed Web of Science 8. McCollum ED , Bjornstad E , Preidis GA , et al. Multicenter study of hypoxemia prevalence and quality of oxygen treatment for hospitalized Malawian children . Trans R Soc Trop Med Hyg . 2013 ; 107 : 285 – 92 . doi: 10.1093/trstmh/trt017 OpenUrl CrossRef PubMed 9. ↵ Subhi R , Adamson M , Campbell H , et al. The prevalence of hypoxaemia among ill children in developing countries: a systematic review . Lancet Infect Dis . 2009 ; 9 : 219 – 27 . doi: 10.1016/S1473-3099(09)70071-4 OpenUrl CrossRef PubMed Web of Science 10. ↵ Izadnegahdar R , Fox MP , Thea DM , et al. Frequency and Trajectory of Abnormalities in Respiratory Rate, Temperature and Oxygen Saturation in Severe Pneumonia in Children . Pediatr Infect Dis J . 2012 ; 31 : 863 – 5 . doi: 10.1097/INF.0b013e318257f8ec OpenUrl CrossRef PubMed 11. ↵ Zhang L , Mendoza-Sassi R , Santos JCH , et al. Accuracy of symptoms and signs in predicting hypoxaemia among young children with acute respiratory infection: a meta- analysis . Int J Tuberc Lung Dis . 2011 ; 15 : 317 – 25 . OpenUrl PubMed 12. ↵ Dyke T , Brown N . Hypoxia in childhood pneumonia: better detection and more oxygen needed in developing countries . BMJ . 1994 ; 308 : 119 – 20 . OpenUrl FREE Full Text 13. ↵ Weber MW , Mulholland EK . Pulse oximetry in developing countries . Lancet . 1998 ; 351 : 1589 . doi: 10.1016/s0140-6736(05)61160-9 OpenUrl CrossRef PubMed 14. ↵ OMS, UNICEF. Modèle de chapitre pour les manuels PCIME. La prise en charge intégrée des maladies de l’enfant . 2001 . 15. ↵ WHO . Revised WHO classification and treatment for childhood pneumonia at health facilities: evidence summaries . Geneva . 2014 . 16. ↵ Funk LM , Weiser TG , Berry WR , et al. Global operating theatre distribution and pulse oximetry supply: an estimation from reported data . The Lancet . 2010 ; 376 : 1055 – 61 . doi: 10.1016/S0140-6736(10)60392-3 OpenUrl CrossRef PubMed Web of Science 17. ↵ Peterson ME , Docter S , Ruiz-Betancourt DR , et al. Pulse oximetry training landscape for healthcare workers in low- and middle-income countries: A scoping review . J Glob Health . 2023 ; 13 : 04074 . doi: 10.7189/jogh.13.04074 OpenUrl CrossRef 18. ↵ Tesfaye SH , Gebeyehu Y , Loha E , et al. Pulse oximeter with integrated management of childhood illness for diagnosis of severe childhood pneumonia at rural health institutions in Southern Ethiopia: results from a cluster-randomised controlled trial . BMJ Open . 2020 ; 10 : e036814 . doi: 10.1136/bmjopen-2020-036814 OpenUrl Abstract / FREE Full Text 19. ↵ Colbourn T , King C , Beard J , et al. Predictive value of pulse oximetry for mortality in infants and children presenting to primary care with clinical pneumonia in rural Malawi: A data linkage study . PLoS Med . 2020 ; 17 : e1003300 . doi: 10.1371/journal.pmed.1003300 OpenUrl CrossRef 20. ↵ Graham HR , Kamuntu Y , Miller J , et al. Hypoxaemia prevalence and management among children and adults presenting to primary care facilities in Uganda: A prospective cohort study . PLOS Glob Public Health . 2022 ; 2 : e0000352 . doi: 10.1371/journal.pgph.0000352 OpenUrl CrossRef 21. ↵ Graham HR , King C , Duke T , et al. Hypoxaemia and risk of death among children: rethinking oxygen saturation, risk-stratification, and the role of pulse oximetry in primary care . The Lancet Global Health . 2024 ; 12 : e1359 – 64 . doi: 10.1016/S2214-109X(24)00209-2 OpenUrl CrossRef PubMed 22. ↵ Olojede OE , Falade AG , Bakare AA , et al. Understanding pulse oximetry adoption in primary healthcare facilities in Nigeria: a realist process evaluation of the INSPIRING- Lagos stabilisation room project. bmjph . 2024;2. doi: 10.1136/bmjph-2024-001211 OpenUrl Abstract / FREE Full Text 23. ↵ Hedible GB , Louart S , Neboua D , et al. Evaluation of the routine implementation of pulse oximeters into integrated management of childhood illness (IMCI) guidelines at primary health care level in West Africa: the AIRE mixed-methods research protocol . BMC Health Serv Res . 2022 ; 22 : 1579 . doi: 10.1186/s12913-022-08982-4 OpenUrl CrossRef PubMed 24. ↵ Greenhalgh T , Wherton J , Papoutsi C , et al. Beyond Adoption: A New Framework for Theorizing and Evaluating Nonadoption, Abandonment, and Challenges to the Scale-Up, Spread, and Sustainability of Health and Care Technologies . Journal of Medical Internet Research . 2017 ; 19 : e367 . doi: 10.2196/jmir.8775 OpenUrl CrossRef PubMed 25. ↵ Pawson R , Tilley N. Realistic Evaluation . SAGE Publications 1997 . 26. ↵ Sarrassat S , Lewis JJ , Some AS , et al. An Integrated eDiagnosis Approach (IeDA) versus standard IMCI for assessing and managing childhood illness in Burkina Faso: a stepped- wedge cluster randomised trial . BMC Health Services Research . 2021 ; 21 : 354 . doi: 10.1186/s12913-021-06317-3 OpenUrl CrossRef PubMed 27. ↵ Hedible GB , Anago G , Lenaud S , et al. What were the challenges and needs before implementing routine pulse oximetry in IMCI consultations at primary health centres in West Africa? Baseline site assessment of the operational AIRE project , 2020 . medRxiv . 2024;2024.10.14.24315436. doi: 10.1101/2024.10.14.24315436 OpenUrl Abstract / FREE Full Text 28. ↵ Pawson R , Tilley N. Realist Evaluation . Sage Publications Ltd . London, UK 2004 . 29. ↵ Van Belle S , Mayhew SH . Public accountability needs to be enforced –a case study of the governance arrangements and accountability practices in a rural health district in Ghana . BMC Health Services Research . 2016 ; 16 : 568 . doi: 10.1186/s12913-016-1836-1 OpenUrl CrossRef 30. ↵ Pawson R , Greenhalgh T , Harvey G , et al. Realist review--a new method of systematic review designed for complex policy interventions . J Health Serv Res Policy . 2005 ; 10 Suppl 1 : 21 – 34 . doi: 10.1258/1355819054308530 OpenUrl CrossRef PubMed 31. ↵ Merton RK . Social Theory and Social Structure . 1968e édition. New York, NY : Macmillan USA 1968 . 32. ↵ Pawson R . How to Think Like a Realist: A Methodology for Social Science . Edward Elgar Publishing 2024 . 33. ↵ Graham HR , Bakare AA , Gray A , et al. Adoption of paediatric and neonatal pulse oximetry by 12 hospitals in Nigeria: a mixed-methods realist evaluation . BMJ Global Health . 2018 ; 3 : e000812 . doi: 10.1136/bmjgh-2018-000812 OpenUrl Abstract / FREE Full Text 34. ↵ Rogers E. Diffusion of Innovations . Fourth edition, New York , Free Press 1995 . 35. Wisdom JP , Chor KHB , Hoagwood KE , et al. Innovation Adoption: A Review of Theories and Constructs . Adm Policy Ment Health . 2014 ; 41 : 480 – 502 . doi: 10.1007/s10488-013-0486-4 OpenUrl CrossRef PubMed 36. ↵ Chaudoir SR , Dugan AG , Barr CH . Measuring factors affecting implementation of health innovations: a systematic review of structural, organizational, provider, patient, and innovation level measures . Implementation Science . 2013 ; 8 : 22 . doi: 10.1186/1748-5908-8-22 OpenUrl CrossRef PubMed 37. ↵ Wong G , Westhorp G , Manzano A , et al. RAMESES II reporting standards for realist evaluations . BMC Medicine . 2016 ; 14 : 96 . doi: 10.1186/s12916-016-0643-1 OpenUrl CrossRef PubMed 38. ↵ Louart S , HEDIBLE GB , Balde H , et al. Acceptability of the routine use of pulse oximeters into the Integrated Management of Childhood Illness guidelines at primary health centers in West Africa: a mixed-methods study . medRxiv . 2024 ;2024.10.16.24315522. doi: 10.1101/2024.10.16.24315522 OpenUrl Abstract / FREE Full Text 39. ↵ Abejirinde I-OO , Zweekhorst M , Bardají A , et al. Unveiling the Black Box of Diagnostic and Clinical Decision Support Systems for Antenatal Care: Realist Evaluation . JMIR mHealth and uHealth . 2018 ; 6 : e11468 . doi: 10.2196/11468 OpenUrl CrossRef 40. ↵ King C , Boyd N , Walker I , et al. Opportunities and barriers in paediatric pulse oximetry for pneumonia in low-resource clinical settings: a qualitative evaluation from Malawi and Bangladesh . BMJ Open . 2018 ; 8 : e019177 . doi: 10.1136/bmjopen-2017-019177 OpenUrl Abstract / FREE Full Text 41. ↵ McCollum ED , King C , Deula R , et al. Pulse oximetry for children with pneumonia treated as outpatients in rural Malawi . Bull World Health Organ . 2016 ; 94 : 893 – 902 . doi: 10.2471/BLT.16.173401 OpenUrl CrossRef 42. ↵ Hernández AR , Hurtig A-K , Dahlblom K , et al. More than a checklist: a realist evaluation of supervision of mid-level health workers in rural Guatemala . BMC Health Serv Res . 2014 ; 14 : 112 . doi: 10.1186/1472-6963-14-112 OpenUrl CrossRef PubMed 43. ↵ Enoch AJ , English M , Network the CI , et al. Variability in the use of pulse oximeters with children in Kenyan hospitals: A mixed-methods analysis . PLOS Medicine . 2019 ; 16 : e1002987 . doi: 10.1371/journal.pmed.1002987 OpenUrl CrossRef 44. ↵ Sarin E , Kumar A , Alwadhi V , et al. Experiences with use of a pulse oximeter multimodal device in outpatient management of children with Acute Respiratory Infection during Covid pandemic . Journal of Family Medicine and Primary Care . 2021 ; 10 : 631 . doi: 10.4103/jfmpc.jfmpc_1410_20 OpenUrl CrossRef 45. ↵ Ginsburg AS , Tawiah Agyemang C , Ambler G , et al. mPneumonia, an Innovation for Diagnosing and Treating Childhood Pneumonia in Low-Resource Settings: A Feasibility, Usability and Acceptability Study in Ghana . PLoS One . 2016 ; 11 : e0165201 . doi: 10.1371/journal.pone.0165201 OpenUrl CrossRef PubMed 46. ↵ Sukums F , Mensah N , Mpembeni R , et al. Promising adoption of an electronic clinical decision support system for antenatal and intrapartum care in rural primary healthcare facilities in sub-Saharan Africa: The QUALMAT experience . International Journal of Medical Informatics . 2015 ; 84 : 647 – 57 . doi: 10.1016/j.ijmedinf.2015.05.002 OpenUrl CrossRef PubMed 47. ↵ Gildas Boris H , Guaniyi SA , Zineb Z , et al. Epidemiology, pathways, patterns of care and Day-14 mortality of severe cases according to hypoxemia among IMCI children using routine Pulse Oximeter decentralized at Primary Healthcare in West Africa: the AIRE cohort study in Burkina Faso, Guinea, Mali and Niger, 2021 - 2022 . medRxiv . 2024 ;2024.10.18.24315758. doi: 10.1101/2024.10.18.24315758 OpenUrl Abstract / FREE Full Text 48. ↵ Pandey P , Zheng Y . Social positioning matters: A socialized affordance perspective of mHealth in India . Information Systems Journal . 2023 ; 33 : 703 – 32 . doi: 10.1111/isj.12421 OpenUrl CrossRef 49. ↵ Greuel M , Sy F , Bärnighausen T , et al. Community Health Worker Use of Smart Devices for Health Promotion: Scoping Review . JMIR Mhealth Uhealth . 2023 ; 11 : e42023 . doi: 10.2196/42023 OpenUrl CrossRef PubMed 50. ↵ Emdin CA , Mir F , Sultana S , et al. Utility and feasibility of integrating pulse oximetry into the routine assessment of young infants at primary care clinics in Karachi, Pakistan: a cross-sectional study . BMC Pediatr . 2015 ; 15 : 141 . doi: 10.1186/s12887-015-0463-z OpenUrl CrossRef 51. ↵ Deci EL , Olafsen AH , Ryan RM . Self-Determination Theory in Work Organizations: The State of a Science . Annual Review of Organizational Psychology and Organizational Behavior . 2017 ; 4 : 19 – 43 . doi: 10.1146/annurev-orgpsych-032516-113108 OpenUrl CrossRef 52. ↵ Agarwal D , Gore M , Kawade A , et al. Feasibility and acceptability of the paediatric pulse oximeter in integrated management of neonatal and childhood illnesses (IMNCI) services by public health facilities: A qualitative study in rural Western India . J Glob Health . 2023 ; 13 : 04105 . doi: 10.7189/jogh.13.04105 OpenUrl CrossRef 53. ↵ Boris HG , Guaniyi SA , Zineb Z , et al. Identification of severe cases with routine Pulse Oximetry use into the Integrated Management of Childhood Illness at Primary Health Centres level in West Africa: A cross-sectional study within the AIRE project in Burkina Faso, Guinea, Mali and Niger, 2021 - 2022 . medRxiv . 2024 ;2024.10.14.24315439. doi: 10.1101/2024.10.14.24315439 OpenUrl Abstract / FREE Full Text 54. ↵ Venkatesh V , Davis F . A Theoretical Extension of the Technology Acceptance Model: Four Longitudinal Field Studies . Management Science. Published Online First : 2000 . 55. ↵ Graham H , Tosif S , Gray A , et al. Providing oxygen to children in hospitals: a realist review . Bull World Health Organ . 2017 ; 95 : 288 – 302 . doi: 10.2471/BLT.16.186676 OpenUrl CrossRef PubMed 56. ↵ Kaunda W , Umali T , Chirwa ME , et al. Assessing Facilitators and Barriers to Referral of Children Under the Age of Five Years at Ndirande Health Centre in Blantyre , Malawi. Glob Pediatr Health . 2021 ; 8 :2333794X211051815. doi: 10.1177/2333794X211051815 OpenUrl CrossRef PubMed 57. ↵ Simoes EAF , Peterson S , Gamatie Y , et al. Management of severely ill children at first- level health facilities in sub-Saharan Africa when referral is difficult . Bull World Health Organ . 2003 ; 81 : 522 – 31 . OpenUrl PubMed Web of Science 58. ↵ Hedible GB , Sawadogo AG , Zair Z , et al. Epidemiology, pathways, patterns of care and Day 14 mortality of severe illnesses according to hypoxemia among IMCI children using routine PO decentralized at PHC level in West Africa: the AIRE cohort study in Burkina Faso, Guinea, Mali and Niger, 2021-2022. Soumis . 59. ↵ Ginsburg AS , Van Cleve WC , Thompson MIW , et al. Oxygen and pulse oximetry in childhood pneumonia: a survey of healthcare providers in resource-limited settings . J Trop Pediatr . 2012 ; 58 : 389 – 93 . doi: 10.1093/tropej/fmr103 OpenUrl CrossRef PubMed 60. ↵ Bergen N , Labonté R . “Everything Is Perfect, and We Have No Problems”: Detecting and Limiting Social Desirability Bias in Qualitative Research . Qual Health Res . 2020 ; 30 : 783 – 92 . doi: 10.1177/1049732319889354 OpenUrl CrossRef PubMed 61. ↵ Ridde V , Olivier de Sardan J-P . The Development World: Conflicts of Interest at All Levels . Revue internationale des études du développement . 2022 ; 247 – 69 . 62. ↵ Rajkotia Y . Beware of the success cartel: a plea for rational progress in global health . BMJ Glob Health . 2018 ; 3 : e001197 . doi: 10.1136/bmjgh-2018-001197 OpenUrl FREE Full Text 63. ↵ Manzano A . The craft of interviewing in realist evaluation . Evaluation . 2016 ; 22 : 342 – 60 . doi: 10.1177/1356389016638615 OpenUrl CrossRef 64. ↵ Gilmore B . Realist evaluations in low- and middle-income countries: reflections and recommendations from the experiences of a foreign researcher . BMJ Global Health . 2019 ; 4 : e001638 . doi: 10.1136/bmjgh-2019-001638 OpenUrl Abstract / FREE Full Text View the discussion thread. Back to top Previous Next Posted January 27, 2025. Download PDF Supplementary Material Email Thank you for your interest in spreading the word about medRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. You are going to email the following Understanding health innovation adoption: A realist evaluation of pulse oximeter implementation in primary care for children under five in four West African countries Message Subject (Your Name) has forwarded a page to you from medRxiv Message Body (Your Name) thought you would like to see this page from the medRxiv website. Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Share Understanding health innovation adoption: A realist evaluation of pulse oximeter implementation in primary care for children under five in four West African countries Sarah Louart , Habibata Balde , Abdourahmane Coulibaly , Abdoua Elhadji Dagobi , Kadidiatou Kadio , Gildas Boris Hedible , Valériane Leroy , Emilie Robert , Valéry Ridde , AIRE study group medRxiv 2025.01.26.25321135; doi: https://doi.org/10.1101/2025.01.26.25321135 Share This Article: Copy Citation Tools Understanding health innovation adoption: A realist evaluation of pulse oximeter implementation in primary care for children under five in four West African countries Sarah Louart , Habibata Balde , Abdourahmane Coulibaly , Abdoua Elhadji Dagobi , Kadidiatou Kadio , Gildas Boris Hedible , Valériane Leroy , Emilie Robert , Valéry Ridde , AIRE study group medRxiv 2025.01.26.25321135; doi: https://doi.org/10.1101/2025.01.26.25321135 Citation Manager Formats BibTeX Bookends EasyBib EndNote (tagged) EndNote 8 (xml) Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Tweet Widget Facebook Like Google Plus One Subject Area Primary Care Research Subject Areas All Articles Addiction Medicine (568) Allergy and Immunology (863) Anesthesia (297) Cardiovascular Medicine (4421) Dentistry and Oral Medicine (443) Dermatology (382) Emergency Medicine (606) Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1507) Epidemiology (15212) Forensic Medicine (30) Gastroenterology (1121) Genetic and Genomic Medicine (6581) Geriatric Medicine (667) Health Economics (996) Health Informatics (4520) Health Policy (1366) Health Systems and Quality Improvement (1611) Hematology (539) HIV/AIDS (1264) Infectious Diseases (except HIV/AIDS) (15906) Intensive Care and Critical Care Medicine (1103) Medical Education (620) Medical Ethics (144) Nephrology (667) Neurology (6580) Nursing (345) Nutrition (998) Obstetrics and Gynecology (1141) Occupational and Environmental Health (956) Oncology (3324) Ophthalmology (970) Orthopedics (369) Otolaryngology (420) Pain Medicine (435) Palliative Medicine (129) Pathology (663) Pediatrics (1689) Pharmacology and Therapeutics (691) Primary Care Research (710) Psychiatry and Clinical Psychology (5432) Public and Global Health (9212) Radiology and Imaging (2193) Rehabilitation Medicine and Physical Therapy (1368) Respiratory Medicine (1194) Rheumatology (593) Sexual and Reproductive Health (709) Sports Medicine (529) Surgery (709) Toxicology (99) Transplantation (288) Urology (265) (function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'9ff48b7b6a0f09d6',t:'MTc3OTM3NjYxMw=='};var a=document.createElement('script');a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: preprint-html

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00
unpaywall
last seen: 2026-05-23T02:00:01.238055+00:00
License: CC-BY-ND-4.0